VEA
RVMD icon

Virtus ETF Advisers’s Revolution Medicines RVMD Stock Holding History

Virtus ETF Advisers’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,582
Closed -$69.2K – 728
2024
Q4 		$69.2K Sell
1,582
-739
-32% -$37.3K 0.03% 381
2024
Q3 		$105K Buy
2,321
+43
+2% +$1.87K 0.05% 371
2024
Q2 		$88.4K Sell
2,278
-1,033
-31% -$38.6K 0.04% 368
2024
Q1 		$107K Sell
3,311
-229
-6% -$6.79K 0.06% 355
2023
Q4 		$102K Sell
3,540
-376
-10% -$9.04K 0.06% 351
2023
Q3 		$108K Sell
3,916
-390
-9% -$11.6K 0.07% 326
2023
Q2 		$115K Buy
4,306
+137
+3% +$3.36K 0.07% 332
2023
Q1 		$90.3K Sell
4,169
-1,602
-28% -$39.4K 0.05% 363
2022
Q4 		$137K Sell
5,771
-443
-7% -$9.42K 0.07% 372
2022
Q3 		$123K Buy
6,214
+45
+0.7% +$989 0.05% 393
2022
Q2 		$120K Sell
6,169
-206
-3% -$4.01K 0.04% 383
2022
Q1 		$163K Sell
6,375
-371
-5% -$8.07K 0.07% 215
2021
Q4 		$170K Buy
6,746
+596
+10% +$16.8K 0.06% 287
2021
Q3 		$169K Sell
6,150
-321
-5% -$9.34K 0.07% 312
2021
Q2 		$205K Sell
6,471
-454
-7% -$15.8K 0.08% 329
2021
Q1 		$318K Buy
6,925
+120
+2% +$5.38K 0.13% 229
2020
Q4 		$269K Sell
6,805
-1,733
-20% -$68.5K 0.11% 281
2020
Q3 		$297K Sell
8,538
-1,163
-12% -$32.2K 0.16% 225
2020
Q2 		$306K Buy
+9,701
New +$305K 0.14% 300

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtus ETF Advisers's RVMD Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Revolution Medicines (RVMD) in Q1 2025, closing a stake of 1,582 shares — an estimated $69.2K sold.

Virtus ETF Advisers first reported a position in RVMD in Q2 2020 and held it in 19 quarters. The position peaked at $318K in Q1 2021. 284 funds tracked by Wall St. Rank hold RVMD as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Revolution Medicines position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 1,582 Revolution Medicines shares in Q1 2025, an estimated $69.2K.
  • Virtus ETF Advisers first reported a position in Revolution Medicines in Q2 2020 and held it in 19 quarters.
  • Virtus ETF Advisers's Revolution Medicines position peaked at $318K in Q1 2021.
  • 284 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.